U.S. Markets open in 1 hr 23 mins

Analysts' Actions: LB MYGN SP EXPE

TheStreet Staff


L Brands
was downgraded to hold at TheStreet Ratings.

Myriad Genetics
was downgraded from market perform to underperform at JMP Securities. Twelve-month price target is $15. BRCA pricing is lower than expected, JMP Securities said.

SP Plus
was upgraded to buy at TheStreet Ratings.

[Read: 4 Stocks Ready for Breakouts]

Stock Comments / EPS Changes

12-month price target was raised at Cantor Fitzgerald. Shares are now seen reaching $75. Checks point to higher site visitation in recent months, Cantor Fitzgerald said. Buy rating.

[Read: What Supplemental Health Care Has Been Costing Us]

Follow TheStreet on Twitter and become a fan on Facebook.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.